Martin van den Bent

Erasmus University Rotterdam

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Medical Imaging Medical Imaging professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (26)

Ahmed Idbaih

Sorbonne Université

FRANCE

View details

Levin Häni

University Hospital of Bern

SWITZERLAND

View details

Riccardo Soffietti

ITALY

View details

Maarten Wijnenga

Erasmus University Rotterdam

NETHERLANDS

View details

Craig Horbinski

Northwestern University

UNITED STATES

View details

Timothy Kaufmann

Associate Professor

Mayo Clinic Minnesota

UNITED STATES

View details

Maximilian Mair

Medical University of Vienna

AUSTRIA

View details

Rita van den Berg-Emons

Erasmus University Rotterdam

NETHERLANDS

View details

Sebastian van der Voort

Erasmus University Rotterdam

NETHERLANDS

View details

Monika Hegi

Prof, PhD

Lausanne University Hospital

SWITZERLAND

View details

Timothy Cloughesy

Director of NeuroOncology Program/Professor

Ronald Reagan UCLA Medical Center

UNITED STATES

View details

Walter Taal

Erasmus University Rotterdam

NETHERLANDS

View details

Stefan Klein

Erasmus University Rotterdam

NETHERLANDS

View details

Pim French

Assoc Prof

Erasmus MC

NETHERLANDS

View details

Francesco Bruno

University of Turin

ITALY

View details

Kate Connor

Assistant Professor

Trinity College Dublin

IRELAND

View details

Annette Byrne

Associate Professor and Principal Investigator

Royal College of Surgeons in Ireland

IRELAND

View details

Matthias Preusser

Medical University

AUSTRIA

View details

Philipp Karschnia

LMU University Hospital

GERMANY

View details

Gianluca Marucci

Fondazione IRCCS Istituto Neurologico Carlo Besta

ITALY

View details

Benjamin M Ellingson

University of California, Los Angeles

UNITED STATES

View details

Karisa Schreck

Assistant Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

Franck Bielle

Full Professor of Neuropathology

Sorbonne Université

FRANCE

View details

Daniel J. Brat

Northwestern University Feinberg School of Medicine

UNITED STATES

View details

Johan Pallud

Head of Neurosurgery

University Hospital of Psychiatry and Psychotherapy

FRANCE

View details

Gerard Ribbers

Erasmus University Rotterdam

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Martin van den Bent

Research Interests

Explore related searches

Contact this professor

Articles (30)

Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas

Author Correction: RANO criteria for response assessment of brain metastases based on amino acid PET imaging

RANO criteria for response assessment of brain metastases based on amino acid PET imaging

The use of minor response, volumetric assessment, and growth rate kinetics as endpoints in grade 1-3 glioma clinical trials: a RANO perspective

Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report

Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect group

Longitudinal analysis of cognitive function in patients treated with postoperative radiotherapy for grade 2 and 3 IDH mutant diffuse glioma

Long-Term Follow-Up Results of Antiseizure Medication Withdrawal in Grade 2 and 3 Glioma Patients

Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 study

How useful is contrast-enhanced MRI in the long-term surveillance of glioma? A multicentre retrospective longitudinal cohort study

Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: a RANO review

The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?

IDH inhibition in gliomas: from preclinical models to clinical trials

Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study

Tumor growth in recurrent glioblastoma—RANO: when to plan the baseline scan?

State of the Art in Low-Grade Glioma Management: Insights From Isocitrate Dehydrogenase and Beyond

H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions

SUPRAMAX-study

Cognition and health-related quality of life in long-term survivors of high-grade glioma: an interactive perspective from patient and caregiver

ACTION

Evaluating the predictive value of glioma growth models for low-grade glioma after tumor resection

Physical fitness and its association with fatigue in patients with low-grade glioma

Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091)

Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection

Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers

Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma

Arterial spin labelling MRI for brain tumour surveillance

Mitotic count is prognostic in IDH-mutant astrocytoma without homozygous deletion of CDKN2A/B.

Long-term survival with IDH wildtype glioblastoma

Collaborators (26)

Ahmed Idbaih

Levin Häni

Riccardo Soffietti

Maarten Wijnenga

Craig Horbinski

Timothy Kaufmann

Maximilian Mair

Rita van den Berg-Emons

Sebastian van der Voort

Monika Hegi

Timothy Cloughesy

Walter Taal

Stefan Klein

Pim French

Francesco Bruno

Kate Connor

Annette Byrne

Matthias Preusser

Philipp Karschnia

Gianluca Marucci

Benjamin M Ellingson

Karisa Schreck

Franck Bielle

Daniel J. Brat

Johan Pallud

Gerard Ribbers

Make your next move.